Fibrocell Science to Present at Wedbush 2014 Life Sciences Management Access Conference

August 5, 2014 8:18 PM

25 0

EXTON, Pa., Aug 05, 2014 (BUSINESS WIRE) -- Fibrocell Science, Inc., (nyse mkt:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that David Pernock, chairman and chief executive officer, and Greg Weaver, senior vice president and chief financial officer, of Fibrocell Science will present at the Wedbush 2014 Life Sciences Management Access Conference at 10:20 a.m. EDT on Tuesday, August 12, 2014, in New York City. Mr. Pernock and Mr. Weaver will discuss the company’s autologous fibroblast technology, its therapeutic candidates in development, and its collaboration with Intrexon Corporation /quotes/zigman/19340425/delayed/quotes/nls/xon XON +0.14% to develop genetically-modified personalized biologics.

A live webcast of the presentation will be available on Fibrocell's website at . The presentation will be archived on the company's website and available for 30 days.

Read more

To category page